$LGND

Ligand Pharmaceuticals Inc

Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA

LGND chart

What traders are saying about $LGND

Latest posts

Ligand Pharmaceuticals Inc news

Ligand Pharmaceuticals Inc key financials

USD2025202420232022
Revenue$268.1M$167.1M$131.3M$196.2M
Net income$124.5M-$4.0M$52.2M-$33.4M
Diluted EPS$6.13$-0.22$2.94$-1.98
Total assets (year end)$1.56B$941.8M$787.2M$762.7M
Cash and equivalents (year end)$174.9M$72.3M$23.0M$45.0M

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

  • 8-K8-K
  • 8-K8-K
  • 8-K/A8-K/A
  • 10-Q10-Q
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 8-K8-K
  • 10-Q10-Q
  • 8-K8-K

About Ligand Pharmaceuticals Inc

Ticker
LGND (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
San Diego, CA
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
886163
Former names
LIGAND PHARMACEUTICALS

Frequently asked questions

What exchange is Ligand Pharmaceuticals Inc listed on?

Ligand Pharmaceuticals Inc trades on the Nasdaq under the ticker symbol LGND.

What industry is Ligand Pharmaceuticals Inc in?

Ligand Pharmaceuticals Inc is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.

Where is Ligand Pharmaceuticals Inc headquartered?

Ligand Pharmaceuticals Inc's business address on file with the SEC is in San Diego, CA.

When does Ligand Pharmaceuticals Inc's fiscal year end?

Ligand Pharmaceuticals Inc's fiscal year ends on December 31.

How much revenue did Ligand Pharmaceuticals Inc report?

Ligand Pharmaceuticals Inc reported $268.1M in revenue for calendar year 2025, according to its SEC filings.